Description

Eperisone is a centrally acting skeletal muscle relaxant with vasodilatory properties, commonly used in research exploring muscle stiffness, pain modulation, and blood flow enhancement . This tablet formulation provides a controlled 50?mg oral dose—suitable for in vitro and in vivo models involving spasticity, neuralgia, vascular responses, and pain remissions.

Manufactured by Qingdao Guohai Biopharmaceutical Co., Ltd., each bottle contains 40 tablets. Approved in China (NMPA H20010657, product code 86904028000199, barcode 6920771140252) .

?? For laboratory research use only. Not for human or veterinary application.

Eperisone Hydrochloride Product Specifications

Eperisone Hydrochloride Mechanism & Research Applications

Eperisone acts by relaxing skeletal and vascular smooth muscles and has a vasodilatory effect. It suppresses spinal reflex excitability, reducing muscle tone and pain responses . Widely used in:

• Spasticity and muscle rigidity models (e.g., spinal-cord injury, stroke, CP)

• Neuropathic and inflammatory pain assays

• Spinal reflex and muscle tone studies

• Vascular flow and ischemia research

Observed Effects & Safety Notes

Preclinical findings include:

• Anti-spastic and vasodilatory outcomes

• Notable side effects: sedation, headache, nausea, allergic rash, gastrointestinal upset, urinary retention, hypotension — particularly at higher dosages

• Rare cases of severe allergic reactions noted

Safety & Handling Guidelines

• Intended Use: Laboratory research only; not for clinical or veterinary use

• Protective Equipment: Gloves, lab coat, goggles required

• Storage: Maintain sealed in a cool, dry environment

• Disposal: Dispose in accordance with institutional chemical-waste protocols

Research Use Disclaimer

This product is intended strictly for laboratory research use only. It is not approved for clinical, therapeutic, diagnostic, or veterinary purposes. Misuse may result in serious health or legal implications. Handle according to institutional safety guidelines and local regulatory requirements.